Prolevi Bio
Limhamn
About Prolevi Bio
Prolevi Bio develops a delayed-release thyroid hormone formulation mimicking the circadian rhythm improving long-term side effects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $280.5K
- Funding stage: Seed
- Last round: Seed (Sep 2022)
- Website: prolevi.bio
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/prolevi-bio-193551 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.